Industrial endocrine disruptors and polycystic ovary syndrome

@article{Palioura2013IndustrialED,
  title={Industrial endocrine disruptors and polycystic ovary syndrome},
  author={Eleni Palioura and E. Diamanti-Kandarakis},
  journal={Journal of Endocrinological Investigation},
  year={2013},
  volume={36},
  pages={1105-1111}
}
Polycystic ovary syndrome (PCOS) is a complex and enigmatic syndrome of unknown origin and etiology enclosing a broad spectrum of phenotypic manifestations. PCOS pathophysiology combines reproductive and metabolic abnormalities into a heterogeneous disorder that has pervasive and devastating health consequences. Inquiring the generative roots of the syndrome, it has become increasingly apparent the role of the environment as a determinant factor. Experimental exposure to industrial endocrine… Expand
Polycystic ovary syndrome – Phenotypes and diagnosis
TLDR
The clinical manifestations and the sequelae of PCOS vary throughout the lifecycle, partly depending on environmental factors which may affect the integral components of the syndrome, namely ovarian steroidogenesis, ovulation and insulin resistance. Expand
Polycystic ovarian syndrome: Environmental/occupational, lifestyle factors; an overview
TLDR
It can be postulated that prenatal exposure to excessive androgens might be responsible for androgenization of the fetus, which in turn may alter the program of differentiating target tissues and the phenotypic characteristics of PCOS can be persuaded by exposure of female offspring to various endogenous and exogenous factors at later life. Expand
The Relation of Serum Omentin-1 Level with Insulin Resistance in Patients with Polycystic Ovary Syndrome and its Relation with Metformin Treatment
Background Polycystic ovary syndrome (PCOS) is still a matter of research looking for the true pathogenesis of this enigmatic syndrome. Although the majority of cases are familial, genetic studiesExpand
NUTREASE POWDER - Nature’s Blend of Dietary Protein Nutrients to Maintain Optimum Health in PCOS Disease
Generally, Polycystic ovary syndrome (PCOS) refers to a set of symptoms due to elevated androgens (male hormones) in females. Signs and symptoms of PCOS include irregular or no menstrual periods,Expand
Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?
TLDR
Levels of BPA were higher in PCOS women, indicating its role in the etiology, and obese women with PCOS significantly worsens the symptoms. Expand
Sex steroid receptors and apoptosis-related proteins are differentially expressed in polycystic ovaries of adult dogs.
TLDR
It is concluded that sex steroid receptors and apoptotic proteins are differentially expressed in the follicles of adult dogs with PCOs. Expand
Current Knowledge and Perceptions of Women about Polycystic Ovarian Syndrome in Nigeria
TLDR
Assessment of current knowledge and perceptions of women in the Nigerian setting found that knowledge about polycystic ovarian syndrome was inadequate; however perception aboutPolycystic Ovarian Syndrome was satisfactory. Expand
Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population?
TLDR
It would be crucial to consider further actions aimed to refine risk assessment at least in vulnerable population, such as foetuses, infants and young children, to prevent metabolic diseases and obesity. Expand
Bisphenol A: Understanding Its Health Effects from the Studies Performed on Model Organisms
TLDR
Rodents, zebrafish, Drosophila, nematodes, crustaceans and echino‐ derms are being used for monitoring the effect of BPA on their life history traits, nervous system, endocrine system, reproductive systems, behaviour, etc., which could help to anticipate what kind of challenges BPA is putting in human life. Expand
PCOS: dalla patogenesi alla terapia, quali novità
TLDR
La terapia della PCOS, in larga parte sintomatica, deve essere personalizzata, tenendo conto dei bisogni individuali della paziente e della eterogeneità clinica di questa sindrome. Expand
...
1
2
...

References

SHOWING 1-10 OF 50 REFERENCES
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications
TLDR
The molecular mechanisms known to underlie the ovarian and metabolic abnormalities characterising PCOS are reviewed, and the putative interdependence between reproductive and metabolic aspects of PCOS, and therapeutic implications for the management of the syndrome are discussed. Expand
Phenotypes and enviromental factors: their influence in PCOS.
TLDR
Diet emerges as the major environmental determinant of PCOS, and AGEs and BPA may act as endocrine disruptors in the pathogenesis of the syndrome. Expand
Longterm management of Polycystic Ovarian Syndrome (PCOS)
TLDR
Lifestyle modifications including dietary changes, increased exercise and weight loss are appropriate first line interventions for many women with PCOS and pharmaceuticals including metformin, lipid lowering agents and oral contraceptives should be tailored to the individual's risk profile and treatment goals. Expand
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.
TLDR
Focused research in identification of candidate genes may provide valuable information and shed some light on the way out of the genomic labyrinth, elucidating the underlying pathophysiology and aiming at a more efficient therapeutic approach of this complicated endocrine disorder. Expand
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.
TLDR
Higher BPA levels inPCOS women compared to controls and a statistically significant positive association between androgens and BPA point to a potential role of this endocrine disruptor in PCOS pathophysiology. Expand
Follicle dynamics and anovulation in polycystic ovary syndrome.
TLDR
Significant abnormalities in the very earliest stages of folliculogenesis may be the root cause of anovulation in PCOS. Expand
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected women have markedExpand
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
TLDR
Animal models that mimic fetal androgen excess may provide unique insight into the origins of the PCOS syndrome, and the prenatally androgenized female rhesus monkey shows particular relevance to PCOS. Expand
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
TLDR
Polycystic ovary syndrome appears to be a particularly common endocrine disorder in the Greek population under study and it is associated with certain metabolic abnormalities, suggesting that the severity of the fasting hyperinsulinemia isassociated with the severity with the clinical phenotype of hyperandrogenism independently of obesity. Expand
Follicular dynamics in the polycystic ovary syndrome
Anovulation in women with polycystic ovary syndrome (PCOS) is characterised by arrested growth of antral follicles. A relative lack of FSH may contribute to the persistence of anovulation but isExpand
...
1
2
3
4
5
...